Table 5.

Cox regression analyses.

	β (s.e.)	z	ĥ (95% c.i.)
Asian or Pacific birthplace (n = 3895)
Cholangiocarcinoma v. combined	−0.25 (0.22)	−1.11	0.78 (0.51–1.2)
Hepatoma v. combined	−0.28 (0.21)	−1.34	0.76 (0.5–1.14)
65 or more years v. younger	0.05 (0.04)	1.37	1.05 (0.98–1.13)
Man v. woman	0.14 (0.04)	3.42*	1.15 (1.06–1.25)
Unstaged v. no metastases	0.45 (0.05)	8.51*	1.57 (1.41–1.74)
Metastases v. no metastases	0.79 (0.04)	18.36*	2.21 (2.03–2.4)
Other birthplace (n = 18658)
Cholangiocarcinoma v. combined	−0.33 (0.07)	−4.83*	0.72 (0.63–0.82)
Hepatoma v. combined	−0.28 (0.07)	−4.28*	0.75 (0.66–0.86)
65 or more years v. younger	0.26 (0.02)	16.24*	1.3 (1.26–1.34)
Man v. woman	0.14 (0.02)	7.8*	1.15 (1.11–1.19)
Unstaged v. no metastases	0.41 (0.02)	19.16*	1.51 (1.45–1.57)
Metastases v. no metastases	0.74 (0.02)	38.71*	2.1 (2.03–2.18)

^*P < 0.025.